The Fight for Botanicals

As the U.S. Food and Drug Administration moves to classify 7-hydroxymitragynine (7-OH)—a naturally occurring compound in kratom—as a controlled substance, advocates warn that banning it could harm consumers who rely on the plant for relief. Kratom, used for centuries in Southeast Asia, is valued in the U.S. for its natural ability to boost energy and ease pain. Supporters say responsible use has helped many reduce dependence on traditional opioids. Dr. Michele Ross of the 7-HOPE Alliance says more research, not prohibition, is the answer. “If you’re a chronic pain patient, your pain doesn’t go away just because something becomes illegal,” she said. Many hope regulators will explore kratom’s therapeutic potential before restricting access.
Source: MSN

JACKSON, Tenn. — Community members and local leaders gathered this month to discuss the future of kratom in Jackson. The Jackson City Council, during its September 2 meeting, raised the idea of introducing regulations on the distribution of the plant-based product.

District 73 Representative Chris Todd emphasized the importance of oversight, noting particular concern around underage sales. While Tennessee currently does not regulate kratom, lawmakers say they will continue exploring options to ensure responsible use and distribution.

The discussion reflects a growing national conversation about kratom, which is used by many adults as a natural product while also drawing attention from policymakers.

For the full report, visit WBBJ 7 Eyewitness News.

The U.S. Food and Drug Administration (FDA) is recommending federal scheduling for highly concentrated kratom products containing synthetic or enhanced 7-hydroxymitragynine (7-OH), a powerful opioid-like compound, following regulatory actions in states like Mississippi. The FDA stresses its proposal does not target natural kratom leaf products, which contain only low levels of 7-OH, but rather focuses on lab-made or fortified products that may contain up to 98% 7-OH.

Mississippi’s new law, HB 1077, bans kratom products with more than 1% 7-OH and restricts sales to those age 21 and over. Advocates argue natural kratom helps people avoid stronger opioids, while critics cite the heightened risk of synthetic products. The debate continues, with more details at the original Northside Sun article and in the FDA’s official press release.

Ohio is currently considering a statewide ban on kratom, but a recent move by the Board of Pharmacy to delay the decision signals recognition of an important distinction: not all kratom products are the same. Governor DeWine’s recommendation would have banned natural kratom leaf alongside newer, more dangerous synthetic derivatives of 7-hydroxymitragynine (7-OH), despite much of the harm and risk stemming from these concentrated synthetic substances, not the traditional plant.

Florida and the FDA offer a model for a targeted approach by restricting 7-OH levels and leaving natural kratom leaf available to consumers. Clinical studies show natural leaf kratom has a safer profile compared to the addictive risks of synthetic 7-OH, which is created by chemical extraction and manipulation and linked to opioid-like effects.

Experts advocate for smart regulation, including age restrictions and alkaloid content limits, to keep consumers safe without eliminating natural kratom. For additional information, visit the source at the Canton Repository.

The conversation around kratom in Ohio is shifting, with state officials and community advocates discussing whether to regulate this increasingly popular plant. Used for centuries in Southeast Asia, kratom has found favor among Ohioans for its energizing and calming effects, often chosen as a gentler alternative to pharmaceuticals and alcohol. Michael Young, owner of Sacred Waters Kava Bar, champions the natural form of kratom, noting its role in holistic wellness and social settings. Many believe responsible use offers benefits such as increased alertness and relief from pain and anxiety. While health professionals emphasize the need for further research to establish safe guidelines, there’s growing support for informed regulation over outright prohibition. The aim is to empower consumers while ensuring safety, continuing kratom’s tradition as a natural well-being option. For more details, visit News 5 Cleveland.

The American Kratom Association (AKA) is taking aim at Shaman Botanicals and founder Stephen “Vince” Sanders, accusing them of sidestepping federal law with their synthetic 7-hydroxymitragynine (7-OH) products. In a statement on August 22, the group argued that 7-OH was marketed illegally from its debut in 2023 because no safety data was ever provided to justify its use.

The AKA emphasized the difference between natural kratom, which has centuries of documented safe use, and 7-OH products synthesized with industrial chemicals. Critics within the association say blaming regulators for scheduling efforts ignores the real problem: manufacturers never proved the products were safe in the first place.

The organization says it will continue working to protect consumers and preserve trust in the natural kratom market.

Full details are available via Reuters.

At a recent Toledo City Council meeting, community members gathered to express their perspectives on the council’s proposal to ban kratom. The discussion highlighted the passionate engagement of local residents, with individuals speaking both for and against the measure. Many supporters of kratom emphasized its positive role for those seeking alternatives for wellness and relief. Their voices illustrated the significance of thoughtful dialogue and community feedback in public policy decisions.

As the city weighs its options, the exchange of ideas demonstrated the values of open debate and respect for diverse viewpoints. Toledo’s consideration of the proposal is part of a broader conversation about personal choice, health, and regulation. For more details on the story, visit The Blade’s coverage of the meeting.

Florida has moved decisively to protect public health, issuing an emergency rule that classifies isolated and concentrated 7-hydroxymitragynine (7-OH) as a Schedule I controlled substance. The action empowers law enforcement to immediately remove concentrated 7-OH products—often found in shots, capsules, powders, and gummies—from retail shelves statewide. Officials cited rising ER visits and poison control calls, particularly among people under 25, as key drivers for the urgent response. Health leaders praised the move as a targeted step to curb access to potent, concentrated derivatives while signaling a broader push for responsible regulation of unregulated wellness products. Enforcement begins immediately, with the goal of keeping communities safe and informed. Read the original report for full details at MSN.

A fresh wave of attention is shining on kratom, a botanical supplement traditionally used for wellness, as Michigan officials move to distinguish between its natural leaf form and a potent derivative, 7-hydroxymitragynine (7-OH). Recent actions from regulatory figures, such as Health and Human Services Secretary Robert F. Kennedy Jr., clarify that while the FDA seeks stricter oversight on 7-OH, the whole kratom leaf remains legally available for adults.

The state’s proposed laws would introduce standards to ensure kratom products are clearly labeled, free from adulterants, and off-limits to those under 18. Advocates praise the approach as protecting both consumer rights and public safety. For a full report on these developments and what they mean for Michigan residents, see the original coverage by the Detroit Free Press.

The American Kratom Association (AKA) has commended Secretary Kennedy and FDA Commissioner Makary for their recent move to specifically regulate synthetic 7-OH, distinguishing it from the widely used natural kratom plant. In a public statement, the AKA described this as a balanced decision that prioritizes consumer safety while preserving lawful access to natural kratom products.

The association highlighted that synthetic 7-OH is a laboratory-made derivative with far greater risk than kratom in its natural form, which is supported by a longstanding record of responsible use. The AKA praised the federal officials for championing a science-driven approach and underscored the significance for the broader kratom community.

By targeting only synthetic compounds, the new scheduling preserves public access to traditional kratom, which the AKA says benefits countless Americans. For full details, see the official release on Reuters.